Annual progress report

Feature stories reflecting the achievements of the Vaccine Alliance and its partners.

22 October 2020

New vaccines to meet emerging needs

Here’s how Gavi helps lower-income countries get the new vaccines and products they need to address urgent threats to public health – from cholera and COVID-19, to Ebola and pneumonia.

23 September 2020

Leaders in the fight against infectious diseases

Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.

21 October 2020

Strengthening supply chains: a long-term investment

The Vaccine Alliance has been working hard in recent years to build greater resilience in supply chains, an effort that is starting to show results.

24 September 2020

Typhoid: immunising against antimicrobial resistance

Typhoid fever is increasingly resistant to the main antibiotics used to treat it. Gavi is supporting a new vaccine to help control this deadly disease – and fight antimicrobial resistance.

20 October 2020

Children who get zero vaccines deserve 100% of our attention

Over 50% more children were immunised in Gavi countries in 2019 than in 2000, yet 10.6 million children continue to miss out entirely on basic vaccinations. Here’s why reaching these children and setting them on the pathway to full immunisation is our highest priority.

19 October 2020

Boosting demand for immunisation

Building and maintaining demand for immunisation is an integral part of Gavi’s work to increase coverage and equity. Here’s an insight into how we have achieved this.

1 October 2020

How Gavi’s co-financing model works

To bring countries on a trajectory towards financial sustainability, and to empower them to take ownership
of their vaccination programmes, Gavi has pioneered an approach to co-financing and transition.

16 October 2020

How innovative finance can fight deadly diseases

One of the vital components to Gavi’s capital structure is the International Finance Facility for Immunisation (IFFIm). A powerful and award-winning financial tool launched in 2006, IFFIm issues Vaccine Bonds on the capital markets against long-term donor pledges.

21 September 2020

Resilience and the risks to global health security

When disaster strikes a country, the impact on people’s health can be immense and long-lasting. As the effects of climate change are felt around the world through rising temperatures and sea levels, natural disasters are increasingly frequent and intense. The aftermath of floods, hurricanes and other severe weather events brings with it the risk of waterborne and respiratory disease outbreaks.

15 October 2020

Taking the long view on vaccine markets

Gavi’s long-term approach to developing healthy markets for critical vaccines has led to greater stability and security, providing countries with the confidence that supplies will be available to meet their demand.

Subscribe to our newsletter